CSIMarket
 

Esperion Therapeutics inc   (ESPR)
Other Ticker:  
 

Esperion Therapeutics Inc 's

Competitiveness


 

ESPR Sales vs. its Competitors Q4 2023







Revenue Growth Comparisons




Net Income Comparison




<<  ESPR Stock Performance Comparisons



*Market share is calculated based on total revenue.

  News about Esperion Therapeutics inc Contracts

Esperion Therapeutics and Daiichi Sankyo Europe Forge Stronger Ties and Resolute Future for Innovative Cardiovascular Solutions

Esperion Therapeutics and Daiichi Sankyo Europe: Strengthening Collaboration and Resolving Commercial Disputes for Future GrowthEsperion Therapeutics, Inc. (NASDAQ: ESPR) and Daiichi Sankyo Europa GmbH (DSE) recently announced a significant expansion of their collaboration, amounting to $125 million. This collaboration includes a mutual resolution of their commercial dispute and other strategic changes aimed at enhancing long-term value for their products. These developments mark an important milestone for both companies and have implications for the broader pharmaceutical industry.Resolving the Dispute: A Win-Win SituationOne of the pivotal aspects of this collaboration is the mutual resolution of the comme...

Esperion and Daiichi Sankyo Europe Forge Ahead with $125 Million Agreement, Resolving Litigation and Ushering Revolutionary Therapies for Hypercholesterolemia

Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending LitigationIn a landmark agreement, Esperion and Daiichi Sankyo Europe have revealed a substantial amendment to their existing collaboration, along with the resolution of a long-standing litigation. The amendment entails a near-term payment of $100 million to Esperion, followed by an additional $25 million in the calendar quarter after the European Medicines Agency (EMA) delivers its decision on Type II(a) variation approval for NILEMDO (bempedoic acid) Tablet and NUSTENDI (bempedoic acid and ezetimibe) Tablet.This groundbreaking partnership amendment marks a significant milestone for bot...





Who are Esperion Therapeutics inc 's Competitors?





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com